Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $8.9200 (-1.44%) ($8.7000 - $9.0000) on Tue. Aug. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 16.71% (three month average) | RSI | 54 | Latest Price | $8.9200(-1.44%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ADAP advances 0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) XBI(23%) XLRE(23%) IWC(22%) DRIV(21%) IWM(21%) | Factors Impacting ADAP price | ADAP will decline at least -8.355% in a week (0% probabilities). TLT(-12%) BNDX(-11%) VXX(-9%) TIP(-9%) BND(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -8.355% (StdDev 16.71%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
Resistance Level | $9.06 | 5 Day Moving Average | $9.06(-1.55%) | 10 Day Moving Average | $9.12(-2.19%) | 20 Day Moving Average | $9.06(-1.55%) | To recent high | -26.3% | To recent low | 72.5% | Market Cap | $1.379b | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |